0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 5
  • 2
  • 2
  • 1

PRICE

0
4
5
10

PUBLISHED

0
1
4
10

PRODUCT TYPE

5
5

Search for: "Intarcia Therapeutics, Inc.-Detailed Product Pipeline"

Intarcia Therapeutics, Inc. - Product Pipeline Review - 2015

Intarcia Therapeutics, Inc. - Product Pipeline Review - 2015 Summary the, ‘Intarcia Therapeutics, Inc. - Product Pipeline Review - 2015’, provides an overview of the Intarcia Therapeutics, Inc.’s...

Published:  July 2015
Price:  From

Intarcia Therapeutics, Inc. - Product Pipeline Review - H2 2011

Intarcia Therapeutics, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Intarcia Therapeutics, Inc. - Product Pipeline Review - H2 2011” provides data...

Published:  November 2011
Price:  From

Intarcia Therapeutics, Inc. - Product Pipeline Review - Q1 2011

Intarcia Therapeutics, Inc. – Product Pipeline Review – Q1 2011 Summary Global Market Direct’s pharmaceuticals report, “Intarcia Therapeutics, Inc. - Product Pipeline Review - Q1 2011” provides data...

Published:  May 2011
Price:  From

Intarcia Therapeutics, Inc. - Product Pipeline Review - Q4 2010

Intarcia Therapeutics, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Intarcia Therapeutics, Inc. - Product Pipeline Review - Q4 2010” provides data...

Published:  November 2010
Price:  From

Intarcia Therapeutics, Inc. - Product Pipeline Review - Q4 2010

Intarcia Therapeutics, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Intarcia Therapeutics, Inc. - Product Pipeline Review - Q4 2010” provides data...

Published:  November 2010
Price:  From

Peptide Therapeutics in Metabolic Disorders, 2016 - 2025

Peptide therapeutics, due to their numerous advantages such as high selectivity, stability, efficacy, safety, bioavailability and tolerability offer a number of benefits over other therapeutic classes....

Published:  February 2016
Price:  From

Obesity - Pipeline Review, H1 2015

Obesity - Pipeline Review, H1 2015 Summary This, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on...

Published:  February 2015
Price:  From

Type 2 Diabetes - Pipeline Review, H2 2015

Type 2 Diabetes - Pipeline Review, H2 2015 Summary The report ‘Type 2 Diabetes - Pipeline Review, H2 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides...

Published:  December 2015
Price:  From

Type 2 Diabetes - Pipeline Review, H1 2015

Type 2 Diabetes - Pipeline Review, H1 2015 Summary This, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

Published:  February 2015
Price:  From

Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins)

Biopharmaceuticals is currently one of the fastest growing segments in the pharmaceutical industry. They have a vital use in the treatment of chronic diseases and also result in high profit margins...

Published:  November 2015
Price:  From
Loading Indicator

Our Clients

  • Goodyear Tire & Rubber Company
  • GlaxoSmithKline PLC
  • Hilton Worldwide
  • Hewlett-Packard Company
  • Accenture PLC.
  • Qualcomm Incorporated
  • UBS AG